CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM NEW
Total 13F shares
191,792
Share change
+42,262
Total reported value
$340,000
Price per share
$1.74
Number of holders
12
Value change
+$72,196
Number of buys
5
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q3 2016

As of 30 Sep 2016, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 191,792 shares. The largest 10 holders included VANGUARD GROUP INC, LADENBURG THALMANN FINANCIAL SERVICES INC, CITADEL ADVISORS LLC, KCG Holdings, Inc., GEODE CAPITAL MANAGEMENT, LLC, BlackRock Advisors LLC, MORGAN STANLEY, UBS Group AG, IFP Advisors, Inc, and BlackRock Fund Advisors. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.